Ikarian Capital’s Amgen AMGN Stock Holding History

Ikarian Capital’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-45,000	Closed	-$14.7M	–	165
2025 Q4	$14.7M	Buy	+45,000	New	+$14.3M	1.15%	26
2024 Q4	–	Sell	-13,300	Closed	-$3.95M	–	173
2024 Q3	$4.29M	Sell	13,300 -25,000	-65%	-$8.18M	0.6%	52
2024 Q2	$12M	Buy	+38,300	New	+$11.3M	2.08%	16
2022 Q2	–	Sell	-20,000	Closed	-$4.9M	–	144
2022 Q1	$4.84M	Buy	+20,000	New	+$4.6M	0.64%	42

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Ikarian Capital's AMGN Position: Q1 2026 in Review

Ikarian Capital sold out of Amgen (AMGN) in Q1 2026, closing a stake of 45,000 shares — an estimated $14.7M sold.

Ikarian Capital first reported a position in AMGN in Q1 2022 and held it in 4 quarters. The position peaked at $14.7M in Q4 2025. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

Ikarian Capital reported no remaining Amgen position as of Q1 2026 after selling out during the quarter.
Ikarian Capital sold 45,000 Amgen shares in Q1 2026, an estimated $14.7M.
Ikarian Capital first reported a position in Amgen in Q1 2022 and held it in 4 quarters.
Ikarian Capital's Amgen position peaked at $14.7M in Q4 2025.
3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Ikarian Capital's 13F filing for Q1 2026, filed 15 May 2026.